Isolation and characterization of microparticles in sputum from cystic fibrosis patients

Chiara Porro1, Silvia Lepore, Teresa Trotta

  • 1Department of Biomedical Sciences, University of Foggia, Foggia, Italy. c.porro@unifg.it

Respiratory Research
|July 13, 2010
PubMed
Abstract

Insights

Microparticles (MPs) are detectable in cystic fibrosis (CF) sputum, primarily originating from granulocytes. This finding offers a new avenue for studying CF lung disease through non-invasive sputum analysis.

Area of Science:

  • Cell Biology
  • Immunology
  • Pulmonology

Background:

  • Microparticles (MPs) are cellular vesicles released during cell activation and apoptosis, with functions varying by origin.
  • Cystic Fibrosis (CF) lung disease involves significant neutrophil influx, activation, and apoptosis in airways.
  • Sputum serves as a valuable, non-invasive source for inflammation biomarker discovery in CF.

Purpose of the Study:

  • To investigate the presence and phenotype of MPs in the sputum of adult CF patients.
  • To compare MP profiles in acute and stable CF disease states.
  • To establish a novel method for MP isolation from sputum for CF research.

Main Methods:

  • Sputum samples from 21 CF patients and 7 primary ciliary dyskinesia (PCD) patients were processed.
  • Microparticles were quantified, visualized via electron microscopy, and identified using flow cytometry and immunolabelling (CD11a, CD66b, CD11b).
  • Bacterial presence in MPs was assessed to rule out contamination.

Main Results:

  • Electron microscopy confirmed sputum MPs ranged from 100-500 nm and were bacteria-free.
  • CF sputa exhibited significantly higher MP counts compared to PCD sputa.
  • Elevated levels of CD11a+ and CD66b+ MPs were observed in CF patients versus PCD patients, irrespective of disease state.

Conclusions:

  • Microparticles are detectable in CF sputum and are mainly of granulocyte origin.
  • The study presents a novel method for isolating MPs from sputum, enabling further research into CF lung pathology.
  • MP analysis in sputum may provide new insights into the inflammatory processes in cystic fibrosis.

Related Concept Videos

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture01:26

Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture

Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...